# A Study Of The Effect Of CJ-023,423 On The Incidence Of Stomach Ulcers

> **NCT00392080** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 340 (estimated)

## Conditions studied

- Osteoarthritis

## Interventions

- **DRUG:** CJ-023,423
- **DRUG:** placebo
- **DRUG:** naproxen

## Key facts

- **NCT ID:** NCT00392080
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-11
- **Primary completion:** —
- **Final completion:** 2008-02
- **Target enrollment:** 340 (ESTIMATED)
- **Last updated:** 2008-03-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00392080

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00392080, "A Study Of The Effect Of CJ-023,423 On The Incidence Of Stomach Ulcers". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00392080. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*